Community-associated meticillin-resistant Staphylococcus aureus
- PMID: 20206987
- PMCID: PMC3511788
- DOI: 10.1016/S0140-6736(09)61999-1
Community-associated meticillin-resistant Staphylococcus aureus
Abstract
Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in individuals with predisposing risk factors, such as surgery or presence of an indwelling medical device. By contrast, many community-associated MRSA (CA-MRSA) infections arise in otherwise healthy individuals who do not have such risk factors. Additionally, CA-MRSA infections are epidemic in some countries. These features suggest that CA-MRSA strains are more virulent and transmissible than are traditional hospital-associated MRSA strains. The restricted treatment options for CA-MRSA infections compound the effect of enhanced virulence and transmission. Although progress has been made towards understanding emergence of CA-MRSA, virulence, and treatment of infections, our knowledge remains incomplete. Here we review the most up-to-date knowledge and provide a perspective for the future prophylaxis or new treatments for CA-MRSA infections.
Copyright 2010 Elsevier Ltd. All rights reserved.
Conflict of interest statement
H.F.C has been a consultant for Johnson and Johnson and has been a consultant and has received research grant support from Pfizer. No conflicts of interest exist for the other authors.
Figures
Comment in
-
Community-associated meticillin-resistant Staphylococcus aureus.Lancet. 2010 Sep 4;376(9743):767; author reply 767. doi: 10.1016/S0140-6736(10)61369-4. Lancet. 2010. PMID: 20816535 No abstract available.
-
Community-associated meticillin-resistant Staphylococcus aureus.Lancet. 2010 Sep 4;376(9743):767-8. doi: 10.1016/S0140-6736(10)61371-2. Lancet. 2010. PMID: 20816537 No abstract available.
References
-
- Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 2001;32(Suppl 2):S114–S132. - PubMed
-
- Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. J Infect Dis. 2008;197:1226–34. - PubMed
-
- von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344:11–16. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
